AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
The firm scrapped its £450m investment despite the government's offer of support, the government says.
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...
Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...
AstraZeneca has cancelled a multi-million pound investment in a vaccine plant in Merseyside because the government failed to ...
Daily Independent on MSN1d
AstraZeneca reaffirms commitment to cancer care on World Cancer Day 2025In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...
AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...
A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...
DUBAI, UAE - Media OutReach Newswire - 28 January 2025 - AstraZeneca, a leading multinational pharmaceutical and ...
Science minister Sir Chris Bryant said the Government feels regretful about the plan being ditched and ‘would prefer to have ...
CORE EARNINGS PER SHARE: Core earnings per share are expected to rise to $2.07 from $1.45 the year prior, according to the same consensus. AstraZeneca's stock is up 7.9% since the start of 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback